期刊
CELL REPORTS
卷 13, 期 6, 页码 1183-1193出版社
CELL PRESS
DOI: 10.1016/j.celrep.2015.09.083
关键词
-
类别
资金
- NIH/NCI [R01CA160331, R01CA163377, K99CA194318, K99CA194309, T32CA9171-35]
- DOD [OC140632P1]
- National Natural Science Foundation [81172009]
- Cancer Center Support Grant (CCSG) [CA010815]
The SPOPgene, which encodes an E3 ubiquitin ligase adaptor, is frequently mutated in a number of cancer types. However, the mechanisms by which SPOP functions as a tumor suppressor remain poorly understood. Here, we show that SPOPpromotes senescence, an important tumor suppression mechanism, by targeting the SENP7 deSUMOylase for degradation. SPOP is upregulated during senescence. This correlates with ubiquitin-mediated degradation of SENP7, which promotes senescence by increasing HP1 alpha sumoylation and the associated epigenetic gene silencing. Ectopic wild-type SPOP, but not its cancer-associated mutants, drives senescence. Conversely, SPOP knockdown overcomes senescence. These phenotypes correlate with ubiquitination and degradation of SENP7 and HP1a sumoylation, subcellular re-localization, and its associated gene silencing. Furthermore, SENP7 is expressed at higher levels in prostate tumor specimens with SPOP mutation (n = 13) compared to those with wild-type SPOP (n = 80). In summary, SPOP acts as a tumor suppressor by promoting senescence through degrading SENP7.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据